5-127331358-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001256545.2(MEGF10):c.50G>A(p.Cys17Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,613,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. C17C) has been classified as Likely benign.
Frequency
Consequence
NM_001256545.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MEGF10 | NM_001256545.2 | c.50G>A | p.Cys17Tyr | missense_variant | 2/25 | ENST00000503335.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MEGF10 | ENST00000503335.7 | c.50G>A | p.Cys17Tyr | missense_variant | 2/25 | 1 | NM_001256545.2 | P1 | |
MEGF10 | ENST00000274473.6 | c.50G>A | p.Cys17Tyr | missense_variant | 3/26 | 1 | P1 | ||
MEGF10 | ENST00000418761.6 | c.50G>A | p.Cys17Tyr | missense_variant | 3/15 | 1 | |||
MEGF10 | ENST00000508365.5 | c.50G>A | p.Cys17Tyr | missense_variant | 2/14 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000195 AC: 49AN: 250982Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135652
GnomAD4 exome AF: 0.000251 AC: 367AN: 1461070Hom.: 1 Cov.: 29 AF XY: 0.000217 AC XY: 158AN XY: 726848
GnomAD4 genome AF: 0.000210 AC: 32AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74300
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 22, 2021 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | MEGF10: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 13, 2021 | - - |
MEGF10-related myopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2022 | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 17 of the MEGF10 protein (p.Cys17Tyr). This variant is present in population databases (rs145733370, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with MEGF10-related conditions. ClinVar contains an entry for this variant (Variation ID: 539961). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The tyrosine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at